About Syneos Health
The Experienced Partner for Clinical Development Services, Global Clinical Trials, Medical Affairs and Commercial Solutions
Who We Are
Syneos Health is the proven partner that helps biopharmaceutical companies navigate complexity from development through commercialization. We move with our customers—leading with expertise, acting with agility and helping advance programs with confidence.
With more than 25,000 professionals operating across 61 countries, we bring the scale of a global organization and the focus of a deeply invested partner to every stage of the journey.
As a leading life sciences services organization, we connect clinical development and commercial capabilities in ways that reduce friction, adapt to change and help programs keep momentum when it matters most.
From Phase I through Phase IV clinical trials to post-approval commercialization, our teams work as an extension of yours: aligned on pace, information and intent, and committed to outcomes that matter for patients everywhere.
What We Do
Syneos Health brings together clinical development services, commercial solutions and technology across the full biopharmaceutical lifecycle.
Our integrated model is built to help customers move faster, make smarter decisions and sustain progress from study startup through launch and beyond.
We manage global clinical trials across therapeutic areas, offering full-service studies, functional service provider (FSP) models, patient recruitment, clinical monitoring, data management and regulatory support from first-in-human studies through late-phase development.
Our teams are built to adapt without losing momentum, pairing scientific and operational expertise with disciplined execution.
Our medical affairs teams help bridge the gap between clinical evidence and the real-world practice of medicine, supporting scientific communications, evidence generation and HCP engagement strategies.
We bring clear judgment, therapeutic depth and stakeholder understanding to help customers communicate with confidence.
From launch readiness and field force deployment to omnichannel engagement and market access, our commercial teams help customers move with speed and precision in complex markets.
We combine commercial expertise, market fluency and responsive execution to support stronger launches and sustained growth.
Technology is built into how we work to support faster insights, fewer handoffs and more responsive execution.
We apply AI and data capabilities where they create practical value—helping optimize operations, surface early signals and strengthen decision-making across development and commercialization.
Our Therapeutic Expertise
Syneos Health has deep therapeutic expertise across complex and highly competitive disease areas.
We bring scientific, operational and market fluency together to help customers navigate complexity, anticipate challenges and move programs forward with confidence.
- Oncology & Hematology: We have contributed to the development or commercialization of 96% of novel oncology drugs approved by the FDA, and 93% of oncology drugs approved by the EMA.
- Cardiovascular & Metabolic Disease
- Cardiovascular
- Endocrine and Metabolic
- Diabetes
- Central Nervous System (CNS)
- Neuroscience
- Rare & Orphan Diseases
- Immunology & Inflammation
- Infectious Disease
- Women’s Health
- Respiratory
Expertise
Syneos Health by the Numbers:
25,000+
professionals worldwide
60+
countries of operation
40+ years
of industry experience
96%
of FDA-approved novel oncology drugs supported
Phase I – Phase IV
full-spectrum clinical capabilities
Named a Leader
in Everest Group’s 2025 Pharmacovigilance Operations PEAK Matrix®
Our Integrated Approach
Most CROs and commercial organizations operate separately, creating handoffs, delays and lost context.
Syneos Health was built differently, bringing clinical development and commercial capabilities together in one organization to support more connected execution from strategy through delivery.
Why Customers Choose Syneos Health
Our work is grounded in five strengths that define what it is like to partner with us:
- Agility that Scales: We adapt without losing momentum, pairing expertise with responsive ways of working that scale to meet complexity across programs, phases and markets.
- Committed Team: We work as part of your team, with shared ownership of outcomes. We are deeply invested from the start, accountable through execution and aligned around your goals, pace and priorities.
- Proactive Guidance: Our teams speak up early, anticipate what is next and quickly shape solutions. We combine deep experience with practical foresight to surface risks sooner and support better decisions.
- Market Fluency: We bring intelligence and sound judgment to navigate complexity, with fluency across market dynamics, therapeutic nuance, stakeholder engagement and local execution realities.
- Technology That Supports Performance: We use AI and connected data to strengthen execution, improve visibility and help teams act faster, but always in service of smarter decisions, better coordination and stronger outcomes.
Our Commitment to Impact
At Syneos Health, every program is ultimately about patients.
Behind every protocol, data set and launch plan is a person waiting for a therapy that could change—or save—their life.
That conviction drives how we work and why we move with urgency, accountability and care.
We are committed to operating with integrity, advancing sustainable business practices and fostering an inclusive culture where our colleagues feel valued and empowered to do their best work.
Our 2025 Impact Report reflects progress across environmental stewardship, workforce equity and ethical governance, as well as our commitment to accountability in the communities we serve.
Our Leadership
Our leaders foster the culture of partnership, accountability and agility that defines Syneos Health, helping teams navigate complexity and move customers' programs forward with confidence.
They provide the continuity and direction that keep teams aligned, decisions clear and progress moving forward for customers and patients alike.
